logo
Select company
Select metric
15.21%Stock Based Compensation Margin
VS
Market
15
Sector
43
Industry
73
History
93
$ 13.83Close
$ 9.55 - $ 70 52-Week Range
Ticker Information

Ticker

KROS

Company Name

KEROS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KEROS THERAPEUTICS INC - Stock Based Compensation Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KROS - SB Comp % Historical data
DateRevenuesStock Based CompensationStock Based Compensation Margin
6/30/2025$ 232.84M$ 35.42M15.21%
3/31/2025$ 214.71M$ 35.66M16.61%
12/31/2024$ 3.55M$ 34.87M982.31%
9/30/2024$ 651K$ 33M5068.51%
6/30/2024$ 271K$ 32.89M12136.53%
3/31/2024$ 234K$ 31.15M13310.26%
12/31/2023$ 151K$ 28.76M19048.34%
9/30/2023$ 8K$ 26.18M327312.5%
6/30/2023$ 0$ 22.23M0%
3/31/2023$ 0$ 19.98M0%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KEROS THERAPEUTICS INC's latest trailing twelve months (TTM) SB Comp % stands at 0%.
  • Over the past 5 years, KEROS THERAPEUTICS INC's average SB Comp % has been 28315.59%.
  • The median SB Comp % for KEROS THERAPEUTICS INC during this period was 3025.41%
  • KEROS THERAPEUTICS INC reached its highest SB Comp % over the past 5 years at 327312.5%.
  • The lowest SB Comp % recorded by KEROS THERAPEUTICS INC in the same timeframe 15.21%

KEROS THERAPEUTICS INC's SB Comp % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

SB Comp % Benchmarks
CompanySB Comp %
MRVI : MARAVAI LIFESCIENCES HOLDINGS INC 18.9%DNA : GINKGO BIOWORKS HOLDINGS INC 33.4%DAWN : DAY ONE BIOPHARMACEUTICALS INC 24.7%RIGL : RIGEL PHARMACEUTICALS INC 4.23%STOK : STOKE THERAPEUTICS INC 14.5%XNCR : XENCOR INC 32.41%AKBA : AKEBIA THERAPEUTICS INC 4.03%ANAB : ANAPTYSBIO INC 28.24%RGNX : REGENXBIO INC 23.5%PHAT : PHATHOM PHARMACEUTICALS INC 22.92%

Definition of Stock Based Compensation Margin

[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for KEROS THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 4.1M ] / Revenues [ $ 0 ]
(=) SB Comp % [ 0% ]

KROS - Stock Based Compensation Margin, Last 5 years

15.21%

Minimum

Jun 30, 2025

327312.5%

Maximum

Sep 30, 2023

28315.59%

Average

3025.41%

Median

SB Comp % Benchmark Analysis

The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
filtered constituents2.99K
min-3.97%
max8.43%
average1.72%
median1.04%
std1.9%